
Senior Director, Respiratory Biology - IPF & ILD
- Stevenage, Hertfordshire
- Permanent
- Full-time
- Scientific Leadership to
- Develop a strategic plan for the next generation of targets in IPF and ILD
- Support the continued development, life cycle innovation, and combinations of the existing clinical portfolio by aligning with the Disease Area Acceleration Team (DAAT) and Product Area Leadership Team (PALT)
- Monitor research and market trends, competitive landscape, and customer insights to identify opportunities and risks, and develop appropriate strategies to maximize market share and revenue.
- Help build a Scientific Advisory Board to foster a network of external experts and key opinion leaders to build an innovative, next generation leary portfolio and advance the existing clinical portfolio.
- Build cross-functional collaborations to perform efficient target selection and progression and support the existing clinical portfolio with key internal partners including other lines within RIRU (clinical and translational teams), Research Technology, Precision Medicine, quantitative science teams and others.
- Establish and maintain external partnerships including collaborations with academic institutions, contract research organizations (CROs), and other external partners to access cutting-edge technologies, complex model systems, bio-samples, and research capabilities.
- Identify/support Business Development for the evaluation and diligence of external opportunities to complement the GSK respiratory portfolio.
- Drive compliance and quality in the discovery of innovative respiratory assets in priority respiratory diseases and mechanisms, ensuring compliance with relevant policies and adhering to quality standards.
- Ph.D. in relevant scientific discipline (e.g., Cell/Molecular Biology, Genetics, Pharmacology, Physical Chemistry or related field) with extensive experience in respiratory biology and pharmaceutical research.
- Extensive experience in the pharmaceutical industry, with a focus on respiratory therapeutics and unmet need in IPF/fibrotic lung disease.
- Experience leading and managing external collaborations and diligence of business development opportunities.
- Proven track record of successfully leading and managing a respiratory portfolio, including research contributions to product launches and lifecycle management.
- Strong knowledge of fibrotic respiratory diseases, pathways and mechanisms, treatment guidelines, and market dynamics.
- Strategic mindset with the ability to work with the Head of Respiratory Biology, the Respiratory Disease Area Acceleration Team (DAAT), the Respiratory Clinical Research Head, and aligned EDLs and MDLs to help interpret complex data and commercial trends, using biological and clinical insights to make informed decisions and provide advice on indication expansion and business development acquisitions.
- Strong business acumen and understanding of commercial aspects, including marketing, sales, and market access.
- Excellent communication and presentation skills, with the ability to effectively engage with internal and external stakeholders.
- Demonstrated ability to work in a fast-paced, dynamic environment and manage multiple priorities.
- Knowledge of regulatory requirements and compliance standards in the pharmaceutical industry.